HBHanneke Bruijnzeel

Hanneke Bruijnzeel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hanneke Bruijnzeel has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Vedat Topsakal

    Cliniques Universitaires Saint Luc

    3 shared publications
  • Aren Bezdjian

    McGill Otolaryngology Sciences Laboratory, McGill University Health Centre—Research Institute Montreal Canada

    1 shared publication
  • Doris van der Heijden

    Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands

    1 shared publication
  • Emily Kay-Rivest

    Department of Otorhinolaryngology and Head and Neck Surgery, Montreal Children’s Hospital, McGill University, Montreal, QC, Canada

    1 shared publication
  • Emily Wammes

    Department of Otolaryngology and Head & Neck Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands

    1 shared publication
  • Fuat Ziylan

    Department of Otorhinolaryngology and Head and Neck Surgery University Medical Center Utrecht

    1 shared publication

Latest Publications

  • Open Access

    Frenulotomy – what are the clinical benefits? A review on the management of tongue-tie

    by Doris van der Heijden, Hanneke Bruijnzeel, Inger-Lise Schuffel, M.L.F. Hol

  • Open Access

    Quality of life (QoL) evaluation of children using cochlear implants: agreement between pediatric and parent proxy-QoL reports

    by Martine Hendriksma, Hanneke Bruijnzeel, Aren Bezdjian, Emily Kay-Rivest, Sam J. Daniel, Vedat Topsakal

    Objectives: Cochlear implants are known to significantly improve the quality of life (QoL) of implanted children. However, variability exists between self-reported outcomes and parental-reported QoL questionnaires. We evaluated the QoL agreement between children and their parents following cochlear implantation and determined which factors lead to increased agreement. Methods: A cross-sectional study was performed including pediatric cochlear implant recipients and their parents. We evaluated postoperative QoL using The Pediatric Quality of Life Inventory (PedsQL). To assess agreement between pediatric and parental QoL perception, PedsQL intra-class correlations (ICCs) were calculated. Results: Thirty-five children and their parents completed QoL questionnaires. Children who were evaluated between 8–12 years of age reported highest absolute total and subscale PedsQL scores. Highest agreement was found amongst parents and children when: (1) children were between 8–12 years at QoL assessment (ICC: between 0.917[95%CI: 0.676–0.981] and 0.972[95%CI: 0.882–0.994]), and (2) when evaluating the physical health QoL domain (ICC: 0.964[95%CI: 0.849–0.992]). Conclusions: This study demonstrates high agreement (ICC > 0.8) between pediatric and parental QoL report in children aged between 8–12 years at QoL assessment. Therefore, results confirm that: (1) QoL agreement between pediatric self-report and parent proxy-report is high in chronically ill children and (2) children using cochlear implants can reliably report QoL between 8–12 years.


  • Open Access

    A retrospective cohort study of adverse event assessment during anesthesia‐related procedures for cochlear implant candidacy assessment and cochlear implantation in infants and toddlers

    by Hanneke Bruijnzeel, Emily Wammes, Robert J. Stokroos, Vedat Topsakal, Jurgen C. de Graaff

    Background Cochlear implantation in childrenwith sensorineural hearing loss is preferably performed at youngest age because early auditory input is essential to prevent neural plasticity decline. In contrast, the rate of anesthetic adverse events is increased during infancy. Therefore, to provide recommendations regarding an optimal pediatric implantation age, these possible anesthetic risks in infants need to be taken into account. Aims This study aimed at assessing the relation between the age at cochlear implant surgery and anesthetic and surgical adverse events. Secondary aims were to evaluateanesthetic and surgical adverse events in relation to: 1) the number of preoperative anesthesia‐related procedures for cochlear implant candidacy assessmentand 2) the anesthetic maintenance agent (total intravenous anesthesia versus inhalation anesthesia) during implantation. Methods We executed aretrospective cohort study to evaluate cochlear implantation performed in infants and toddlers between January 2008 and July 2015in a tertiary pediatric center. We compared anesthetic and surgical adverse events between age‐at‐implantation (0‐12 and 12‐24 months of age) groups.Furthermore, we assessed whether anesthetic adverse events occurred during preoperative anesthesia‐related procedures for cochlear implant candidacy assessment. Results Forty‐six cochlear implantations were performed in 43 patients requiring 42preoperative anesthesia‐related procedures. Nineteen cochlear implantations (41.3%) were performed during infancy. During implantation, the maintenance agent was either sevoflurane (n =22) or propofol (n =24).None of the patients encountered majoranestheticadverse events, whereas minor adverse events occurred during 34 cochlear implantations. Those attributed to surgery occurred followingsiximplantations. Neither the age at implantation nor the anesthetic maintenance agent was significantly related to the occurrence of both types of adverse events. Conclusions Adverse events occur independent of the age at implantation,the number of anesthetic preoperative procedures and the type of anesthetic maintenance agent in patientswho received a cochlear implant before 24 months of age.


  • Open Access

    A Systematic Review to Define the Speech and Language Benefit of Early (<12 Months) Pediatric Cochlear Implantation

    by Hanneke Bruijnzeel, Fuat Ziylan, Inge Stegeman, Vedat Topsakal, Wilko Grolman

    Objective: This review aimed to evaluate the additional benefit of pediatric cochlear implantation before 12 months of age considering improved speech and language development and auditory performance. Materials and Methods: We conducted a search in PubMed, EMBASE and CINAHL databases and included studies comparing groups with different ages at implantation and assessing speech perception and speech production, receptive language and/or auditory performance. We included studies with a high directness of evidence (DoE). Results: We retrieved 3,360 articles. Ten studies with a high DoE were included. Four articles with medium DoE were discussed in addition. Six studies compared infants implanted before 12 months with children implanted between 12 and 24 months. Follow-up ranged from 6 months to 9 years. Cochlear implantation before the age of 2 years is beneficial according to one speech perception score (phonetically balanced kindergarten combined with consonant-nucleus-consonant) but not on Glendonald auditory screening procedure scores. Implantation before 12 months resulted in better speech production (diagnostic evaluation of articulation and phonology and infant-toddler meaningful auditory integration scale), auditory performance (Categories of Auditory Performance-II score) and receptive language scores (2 out of 5; Preschool Language Scale combined with oral and written language skills and Peabody Picture Vocabulary Test). Conclusions: The current best evidence lacks level 1 evidence studies and consists mainly of cohort studies with a moderate to high risk of bias. Included studies showed consistent evidence that cochlear implantation should be performed early in life, but evidence is inconsistent on all speech and language outcome measures regarding the additional benefit of implantation before the age of 12 months. Long-term follow-up studies are necessary to provide insight on additional benefits of early pediatric cochlear implantation.